ACTRN12619000654156尚未招募未知
Can providing information about a generic medicine switch reduce side effect reporting in patients taking lamotrigine for epilepsy and bipolar disorder?
Professor Keith Petrie0 个研究点目标入组 1,500 人开始时间: 2019年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Participants must be a patient of Green Cross Health - a New Zealand provider of primary care services. They must be taking either Lamictal or Arrow-lamotrigine before the medicine change. They must have a mobile phone number on file in the Green Cross database.
排除标准
- •Are taking Logem before the switch (i.e. will not be switching medicine brands) and do not have a mobile phone number in the Green Cross database
研究者
相似试验
已完成
不适用
The effect of different types of medicine information on side effect reportingGeneral medication usePublic Health - Health promotion/educationACTRN12620000735954Professor Keith Petrie116
尚未招募
不适用
Partnering with Patients in Medication Administration: Testing the effect of a information brochure for patients on medication administration errorsMedication errorInjuries and Accidents - Other injuries and accidentsACTRN12616001280493Alison Hutchinson7,200
招募中
1 期
Clinical study on the treatment of advanced rheumatoid arthritis (Phlegm stasis bi syndrome) by Soufeng Sanjie fomula for inhibiting bone erosioRheumatoid arthritisITMCTR2200006853Jiangsu Integrated Traditional Chinese and Western Medicine Hospital
Unknown
1 期
Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand PreparationsHealthyNCT01400165University of Ottawa30
尚未招募
3 期
Verifying the rubrics Food and Drinks in Synthesis RepertoryCTRI/2024/02/063332I